Eur Rev Med Pharmacol Sci 2020; 24 (18): 9244-9245
DOI: 10.26355/eurrev_202009_23005

Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism

S. Haque, A. Jawed, N. Akhter, S.A. Dar, F. Khan, R.K. Mandal, M.Y. Areeshi, M. Lohani, M. Wahid

Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan, Saudi Arabia. wahidbiochem@gmail.com

Free PDF Download

To cite this article

S. Haque, A. Jawed, N. Akhter, S.A. Dar, F. Khan, R.K. Mandal, M.Y. Areeshi, M. Lohani, M. Wahid
Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 18
Pages: 9244-9245
DOI: 10.26355/eurrev_202009_23005

Keywords Related articles:

  1. Effect of temperature and humidity on the dynamics of daily new cases and deaths due to COVID-19 outbreak in Gulf countries in Middle East Region
  2. Correlation between the embolism area and pulmonary arterial systolic pressure as an indicator of pulmonary arterial hypertension in patients with acute pulmonary thromboembolism
  3. Effects of N-acetyl-cysteine and acetylsalicylic acid on the tonsil bacterial biofilm tissues by light and electron microscopy
  4. No infectious risk of COVID-19 patients with long-term fecal 2019-nCoV nucleic acid positive
  5. An “alternative” clinical course of COPD exacerbation and pulmonary embolism